Sharps Technology Secures Private Round Financing on August 25, 2025

According to media reports, Sharps Technology completed a Private round of financing on August 25, 2025. This round saw participation from institutions including Pantera Capital, ParaFi Capital, Borderless Capital, CoinFund, Arrington Capital, Primitive Ventures, Hypersphere Ventures, FalconX, RockawayX, and Quantstamp.Sharps Technology is a Nasdaq-listed medical device company (ticker: STSS) focused on the research, development, and manufacturing of innovative safety syringes. The company’s core mission is to reduce the risk of disease transmission caused by needlestick injuries through its technology, thereby protecting healthcare professionals, patients, and the public while enhancing the accuracy and efficiency of drug delivery. Recently, the company announced the establishment of an SOL treasury, underscoring its strategic positioning in digital assets.Notably, public information indicates that following this financing round, Sharps Technology rapidly expanded its fundraising scale to USD 1 billion and initiated its digital asset treasury strategy. As of September 2, 2025, the company’s SOL holdings exceeded 2 million tokens, demonstrating its cross-sector development in both traditional medical devices and digital asset innovation. This strategic move not only highlights the company’s innovative approach to digital asset management but also sets a new benchmark for digital transformation among traditional medical technology enterprises.